NCI Search Results

Results for: Burkitt's Lymphoma

Results 21–30 of 821 for: Burkitt's Lymphoma

  • In a large international collaborative analysis of risk factors for non-Hodgkin lymphoma (NHL), scientists were able to quantify risk associated with medical history, lifestyle factors, family history of blood or lymph-borne cancers, and occupation for 11
  • DCEG conducts research on cancers of the white blood cells, known as lymphomas. DCEG's work includes studies of Burkitt lymphoma, Hodgkin lymphoma, and non-Hodgkin lymphoma and its subtypes.
  • Highlights of cancer genomics research and programs from the March 2019 edition of the Office of Cancer Genomics (OCG) e-Newsletter
  • CGH sponsors a number of global health events for both national and international audiences, focused on the open exchange of scientific knowledge.
  • This Childhood Cancer Genomics summary provides a brief synopsis of current knowledge about the genomic landscape of specific childhood cancers. Get detailed information about various genetic alterations and precision medicine concepts in childhood cancers in this summary for clinicians.
  • AIDS-related lymphoma treatment may include chemotherapy, radiation therapy, high-dose chemotherapy with stem cell transplant, and/or targeted therapy. Get detailed information about newly diagnosed and recurrent AIDS-related lymphoma and treatment in this expert-reviewed summary.
  • Summary of speakers and events from the 2008 ICMAOI conference, focused on presenting basic, epidemiologic, and clinical aspects of research on malignancies in HIV-infected and other immunosuppressed individuals.
  • Adult acute lymphoblastic leukemia (ALL) treatment options include chemotherapy, radiation therapy, stem cell transplant, and targeted therapy. Get detailed information about the molecular genetics, prognosis, and treatment of ALL in this summary for clinicians.

Results 21–30 of 821.

Show results per page.

821 results found for: Burkitt's Lymphoma